Junzo Hamanishi

11.0k citations

142 papers · 7.4k indexed · 6 hit papers · h-index 33

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer

Papers in

Reproductive Medicine 56
- Ovarian cancer diagnosis and treatment 46
Obstetrics and Gynecology 44
- Endometrial and Cervical Cancer Treatments 28
- Uterine Myomas and Treatments 15

Co-authors: Masaki Mandai Ken Yamaguchi Ikuo Konishi Noriomi Matsumura Tsukasa Baba Kaoru Abiko Tasuku Honjo Ryusuke Murakami
Journals: International Journal of Clinical Oncology (8 papers)Journal of Gynecologic Oncology (8 papers)Gynecologic Oncology (7 papers)Clinical Cancer Research (6 papers)Scientific Reports (4 papers)
Partner nations: Japan United States Canada

In The Last Decade

Junzo Hamanishi

134 papers receiving 7.3k citations

Hit Papers

6 papers align trajectories log scale

Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition 2021 · 227 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Clinical Cancer Research
2018 Journal of Clinical Investigation
2017 Journal of Biomedical Science
2015 Cancer Research
2015 British Journal of Cancer
2007 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Junzo Hamanishi

Since Specialization

Citations

This map shows the geographic impact of Junzo Hamanishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junzo Hamanishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junzo Hamanishi more than expected).

Fields of papers citing papers by Junzo Hamanishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junzo Hamanishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junzo Hamanishi. The network helps show where Junzo Hamanishi may publish in the future.

Co-authors

The 25 scholars most cited alongside Junzo Hamanishi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Junzo Hamanishi Line = papers co-authored together Junzo Hamanishi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial Journal of Gynecologic Oncology ·Shin Nishio, Tadaaki Nishikawa, Masahiko Mori, Shoji Kamiura, Toshiyuki Sumi, Mayu Yunokawa, Yuichi Imai, Eiji Kondo, Kazuhiro Takehara, Hirokuni Takano, Wataru Kudaka, Nobuhiro Kado, Wataru Yamagami, 宋锴, В А Смирнов, Tomoka Usami, Junzo Hamanishi, Masahiro Nii, Veronica Pittari, Aikou Okamoto	2025	0
2	A Deep Learning–Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma American Journal Of Pathology ·Johannes VanDerBeek, Ryusuke Murakami, Akihiko Ueda, René. Expert Berthéol, Per Rin A, Mana Taki, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Sachiko Minamiguchi, Noriomi Matsumura, Masaki Mandai	2024	4
3	Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian Cancer American Journal Of Pathology ·Akihiko Ueda, Hidekatsu Nakai, Per Rin A, Tomoyuki Otani, Manabu Yoshida, Ryusuke Murakami, Shinichi Komiyama, Terumi Tanigawa, В. П. Данилов, Hirokuni Takano, Tsukasa Baba, Kiyonori Miura, Muneaki Shimada, Junzo Kigawa, Takayuki Enomoto, Junzo Hamanishi, Jesus Consuegra, Yasushi Okuno, Masaki Mandai, Noriomi Matsumura	2024	1
4	YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma Molecular Cancer Therapeutics ·烈竹中, Ken Yamaguchi, Koji Yamanoi, S. V. Esipov, Shiro Takamatsu, Mana Taki, Masayo Ukita, Yuko Hosoe, Ryusuke Murakami, Kaoru Abiko, Akihito Horie, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai	2024	7
5	An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group Journal of Gynecologic Oncology ·Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto	2023	2
6	Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy Journal for ImmunoTherapy of Cancer ·Shiro Takamatsu, Junzo Hamanishi, J.B. Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura	2022	4
7	Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics Journal of Gynecologic Oncology ·Ikuo Konishi, Kaoru Abiko, Takuma Hayashi, Koji Yamanoi, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai	2022	10
8	Polarity switching of ovarian cancer cell clusters via SRC family kinase is involved in the peritoneal dissemination Cancer Science ·Hiba Al-Assaad, Jumpei Kondo, Kunishige Onuma, Yu Ito, В. П. Данилов, Junzo Hamanishi, Masaki Mandai, Tadashi Kimura, Masahiro Inoue	2022	10
9	Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after “IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer” British Journal of Cancer ·Kaoru Abiko, Junzo Hamanishi, Noriomi Matsumura, Masaki Mandai	2022	23
10	Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer Journal of Gynecologic Oncology ·Kazuhiro Takehara, Takashi Matsumoto, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Kimio Ushijima, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Yanze Li, Ajit Suri, Hiroaki Itamochi, Nobuhiro Takeshima	2021	9
11	The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients Journal of Gynecologic Oncology ·Samridhi Sinha, Taito Miyamoto, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai	2019	10
12	Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma Journal of Gynecologic Oncology ·Nickole Criner, Ken Yamaguchi, Yasuhisa Kurata, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Eiji Kondoh, Tsukasa Baba, Aki Kido, Ikuo Konishi, Noriomi Matsumura	2017	4
13	Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells Clinical Cancer Research ·Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Tsukasa Baba, Ken Yamaguchi, Yumiko Yoshioka, Masafumi Koshiyama, Ikuo Konishi	2016	228
14	Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer Journal of Gynecologic Oncology ·Ashton Morelock, Ken Yamaguchi, Noriomi Matsumura, Hidekatsu Nakai, Yumiko Yoshioka, Eiji Kondoh, Junzo Hamanishi, Kaoru Abiko, Masafumi Koshiyama, Tsukasa Baba, Aki Kido, Masaki Mandai, Ikuo Konishi	2016	9
15	癌治療におけるPD‐1/PD‐L1阻害:展望と問題 International Journal of Clinical Oncology ·Junzo Hamanishi, Masaki Mandai, Katrina L. Cooper, Kaoru Abiko, Tsukasa Baba, Ikuo Konishi	2016	1
16	Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer Cancer Research ·Peng Jin, Junzo Hamanishi, Noriomi Matsumura, Kaoru Abiko, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Yuko Hosoe, Susan K. Murphy, Ikuo Konishi, Masaki Mandai Hit paper breakdown →	2015	437
17	STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer Cancer Research ·Budiman Kharma, Tsukasa Baba, Noriomi Matsumura, Hyun Kang, Junzo Hamanishi, Ryusuke Murakami, K. Nagakura, Samuel Leung, Ken Yamaguchi, Yuko Hosoe, Yumiko Yoshioka, Susan K. Murphy, Masaki Mandai, Juan Pablo Villate Diaz, Ikuo Konishi	2014	62
18	PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction Clinical Cancer Research ·Kaoru Abiko, Masaki Mandai, Junzo Hamanishi, Yumiko Yoshioka, Noriomi Matsumura, Tsukasa Baba, Ken Yamaguchi, Ryusuke Murakami, Ayaka Yamamoto, Budiman Kharma, Kenzo Kosaka, Ikuo Konishi	2013	187
19	GPR54 Is a Target for Suppression of Metastasis in Endometrial Cancer Molecular Cancer Therapeutics ·Hyun Kang, Tsukasa Baba, Masaki Mandai, Noriomi Matsumura, Junzo Hamanishi, Budiman Kharma, Eiji Kondoh, Yumiko Yoshioka, Shinya Oishi, Nobutaka Fujii, Susan K. Murphy, Ikuo Konishi	2011	33
20	Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 ⁺ T lymphocytes are prognostic factors of human ovarian cancer Proceedings of the National Academy of Sciences ·Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato, Tasuku Honjo, Shingo Fujii Hit paper breakdown →	2007	1155

About Junzo Hamanishi

Junzo Hamanishi is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Immunology and Cancer Research, having authored 142 papers that have together received 7.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (46 papers), Cancer Immunotherapy and Biomarkers (31 papers), Endometrial and Cervical Cancer Treatments (28 papers), Immune Cell Function and Interaction (17 papers), Uterine Myomas and Treatments (15 papers), Maternal and fetal healthcare (12 papers), Immune cells in cancer (12 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Reproductive Medicine (1.4k citations), Immunology (3.6k citations), Oncology (4.4k citations), Obstetrics and Gynecology (646 citations) and Cancer Research (873 citations). Junzo Hamanishi has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Masaki Mandai, Ken Yamaguchi, Ikuo Konishi, Noriomi Matsumura, Tsukasa Baba, Kaoru Abiko, Tasuku Honjo, Ryusuke Murakami, Naoki Horikawa and Kenji Takakura. Their work appears in journals such as International Journal of Clinical Oncology, Journal of Gynecologic Oncology, Gynecologic Oncology, Clinical Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact